2016
DOI: 10.3390/molecules21050658
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells

Abstract: Abstract:The nasal route receives a great deal of attention as a non-invasive method for the systemic administration of drugs. For nasal delivery, specific formulations containing excipients are used. Because of the sensitive respiratory mucosa, not only the active ingredients, but also additives need to be tested in appropriate models for toxicity. The aim of the study was to measure the cytotoxicity of six pharmaceutical excipients, which could help to reach larger residence time, better permeability, and in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
12
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 15 publications
0
12
0
Order By: Relevance
“…Our primary objective, in fact, was to demonstrate the biocompatibility of cationic beta-cyclodextrin monomers and polymers and thus suggesting their use for nasal formulations. All cationic beta-cyclodextrin polymers, QAPS and HAPS, show dose- and time-dependent toxicity; nevertheless, at 5 µM concentration and 60 min of exposure, the cell viability value is about 80% for QAPS and thus it could be recognized as nontoxic [ 24 , 25 , 26 ]. HAPS has low toxic effect at 5 µM concentration and 60 min of exposition.…”
Section: Discussionmentioning
confidence: 99%
“…Our primary objective, in fact, was to demonstrate the biocompatibility of cationic beta-cyclodextrin monomers and polymers and thus suggesting their use for nasal formulations. All cationic beta-cyclodextrin polymers, QAPS and HAPS, show dose- and time-dependent toxicity; nevertheless, at 5 µM concentration and 60 min of exposure, the cell viability value is about 80% for QAPS and thus it could be recognized as nontoxic [ 24 , 25 , 26 ]. HAPS has low toxic effect at 5 µM concentration and 60 min of exposition.…”
Section: Discussionmentioning
confidence: 99%
“…Our primary objective, in fact, was to demonstrate the biocompatibility of cationic beta-cyclodextrin monomers and polymers and thus suggesting their use for nasal formulations. All cationic beta-cyclodextrin polymers, QAPS and HAPS, show dose-and time-dependent toxicity; nevertheless, at 5 µ M concentration and 60 min of exposure, the cell viability value is about 80% for QAPS and thus it could be recognized as non-toxic [24][25][26]. HAPS has low toxic effect at 5 µ M concentration and 60 min of exposition.…”
Section: Discussionmentioning
confidence: 99%
“…Rita Ambrus and coworkers studied the cytotoxicity of six pharmaceutical excipients, which could help to reach larger residence time, better permeability, and an increased solubility dissolution rate. As described in the communication entitled “Cytotoxicity of Different Excipients on RPMI 2650 Human Nasal Epithelial Cells” [ 11 ], they found that all additives at 0.3% sodium hyaluronate and polyvinyl alcohol at 1% concentrations can be safely used for nasal formulations.…”
mentioning
confidence: 99%